Literature DB >> 3204397

Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders.

D Aubby1, H K Saggu, P Jenner, N P Quinn, A E Harding, C D Marsden.   

Abstract

Leukocyte glutamate dehydrogenase (GDH) activity was measured in 39 normal subjects, 32 neurological controls, 66 patients with progressive ataxic disorders, 32 with multiple system atrophy, 40 with Parkinson's disease, eight with Steele-Richardson-Olszewski syndrome, eight with juvenile Parkinsonism and four with the dystonia-Parkinsonism syndrome. GDH activity was reproducible to within 10% in leukocyte pellets stored at -70 degrees C for up to 9 months, and did not vary with sex or age in control subjects. There was marked variation in the relative proportions of heat stable and heat labile forms of GDH between control subjects and on repeated assay in the same subject. Total leukocyte GDH activity was similar in normal subjects and neurological controls. Mean total GDH activity was reduced in all patient groups by between 15 to 29% compared with controls. Fourteen patients had total GDH activity below 50% of the control mean, but low values were not specific for any one disease (five had ataxic disorders, four Parkinson's disease, three multiple system atrophy, one juvenile Parkinsonism, and one dystonia-Parkinsonism). The heat labile fraction of GDH represented about 20% of total activity in control subjects, and 27% in the patients with reduced total GDH activity. Thus low GDH activity was not disease-specific in this study, and the heat-labile GDH fraction was not selectively affected. "Reduced" leucocyte GDH activity in some patients may represent no more than the lower end of a normal distribution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3204397      PMCID: PMC1033190          DOI: 10.1136/jnnp.51.7.893

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder.

Authors:  A Plaitakis; S Berl; M D Yahr
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

Review 2.  The neuropathology of olivopontocerebellar atrophy.

Authors:  A H Koeppen; K D Barron
Journal:  Adv Neurol       Date:  1984

3.  Olivopontocerebellar atrophy. A review of 117 cases.

Authors:  J Berciano
Journal:  J Neurol Sci       Date:  1982-02       Impact factor: 3.181

4.  Neurological disorders associated with deficiency of glutamate dehydrogenase.

Authors:  A Plaitakis; S Berl; M D Yahr
Journal:  Ann Neurol       Date:  1984-02       Impact factor: 10.422

5.  The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'.

Authors:  A E Harding
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

6.  Glutamate dehydrogenase and its isozyme activity in olivopontocerebellar atrophy.

Authors:  Y Konagaya; M Konagaya; T Takayanagi
Journal:  J Neurol Sci       Date:  1986-07       Impact factor: 3.181

7.  "Idiopathic" late onset cerebellar ataxia. A clinical and genetic study of 36 cases.

Authors:  A E Harding
Journal:  J Neurol Sci       Date:  1981-08       Impact factor: 3.181

8.  Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome.

Authors:  A Plaitakis; W J Nicklas; R J Desnick
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

9.  Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy.

Authors:  R C Duvoisin; S Chokroverty; F Lepore; W Nicklas
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

10.  Glutamate dehydrogenase deficiency in spinocerebellar degenerations.

Authors:  T Yamaguchi; K Hayashi; H Murakami; K Ota; S Maruyama
Journal:  Neurochem Res       Date:  1982-05       Impact factor: 3.996

View more
  4 in total

1.  Leukocyte glutamate dehydrogenase in patients with degenerative neurological disorders.

Authors:  A Plaitakis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

2.  Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.

Authors:  S Malessa; P N Leigh; O Bertel; E Sluga; O Hornykiewicz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

3.  DIDMOAD syndrome; further studies and muscle biochemistry.

Authors:  T G Barrett; K Poulton; S Bundey
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry.

Authors:  S Chokroverty; W Nicklas; D C Miller; J Goldberg; J Choe; C Banner; J Thomas; R Duvoisin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.